[Through the Glass Door] Barclays Global Investors and Genentech: Stuck in the M & A Middle?

In Roman Catholic theology, limbo is that afterlife condition for those who die without being assigned to hell. For employees in companies waiting for the post-acquisition dust to settle such as Genentech, or for those waiting for part of the organization to be halved off, such as Barclays Global Investors (BGI) with its iShares division,  limbo is a pretty good description of what it’s like to be inside the organization.Read the rest